Skip to Content

300 PLZID (Zidovudine 300 mg)

Pill with imprint 300 PLZID is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Teva Pharmaceuticals USA.

Zidovudine is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure; reduction of perinatal transmission of hiv and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 300 PLZID

Zidovudine

Imprint
300 PLZID
Strength
300 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-5530

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.